scispace - formally typeset
R

Ramón Corbalán

Researcher at University of Chile

Publications -  20
Citations -  5551

Ramón Corbalán is an academic researcher from University of Chile. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 11, co-authored 20 publications receiving 5106 citations. Previous affiliations of Ramón Corbalán include Pontifical Catholic University of Chile.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky, +2522 more
- 01 Jan 2016 - 
TL;DR: Author(s): Klionsky, DJ; Abdelmohsen, K; Abe, A; Abedin, MJ; Abeliovich, H; A Frozena, AA; Adachi, H, Adeli, K, Adhihetty, PJ; Adler, SG; Agam, G; Agarwal, R; Aghi, MK; Agnello, M; Agostinis, P; Aguilar, PV; Aguirre-Ghis
Journal ArticleDOI

C-reactive protein and atrial fibrillation: “Evidence for the presence of inflammation in the perpetuation of the arrhythmia”

Mónica Acevedo, +5 more
- 14 Apr 2006 - 
TL;DR: There is evidence for the presence of inflammation in patients with non-valvular AF, which is not related to activation of the coagulation cascade, and the persistence of inflammation is associated with chronic AF at 1-year follow up.
Journal ArticleDOI

Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status.

Mónica Acevedo, +6 more
- 01 Feb 2003 - 
TL;DR: Although the administration of growth hormone to patients with advanced cardiac heart failure was associated with a significant increase in insulin growth factor-1, there were no significant changes in ejection fraction, exercise capacity and/or neurohormonal status.
Journal ArticleDOI

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction 30

Bertram Pitt, +9 more
- 01 May 2006 - 
TL;DR: Because of the prognostic importance of LV dysfunction following an AMI and the increasing use of electrical and/or mechanical interventions in patients with LV systolic dysfunction, this retrospective analysis of EPHESUS patients with LVEF ≤30% at baseline was conducted to determine the value of eplerenone in this setting.